Basket

0562691 - FGÚ 2023 RIV NL eng J - Journal Article
Beňová, Andrea - Ferenčáková, Michaela - Bardová, Kristina - Funda, Jiří - Procházka, Jan - Špoutil, František - Čajka, Tomáš - Džubanová, Martina - Balcaen, T. - Kerckhofs, G. - Willekens, W. - van Lenthe, G. H. - Alquicer, Glenda - Pecinová, Alena - Mráček, Tomáš - Horáková, Olga - Rossmeisl, Martin - Kopecký, Jan - Tencerová, Michaela
Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones.
Molecular Metabolism. Roč. 65, Nov (2022), č. článku 101598. ISSN 2212-8778. E-ISSN 2212-8778
R&D Projects: GA ČR(CZ) GA20-03586S; GA ČR(CZ) GA19-02411S; GA MŠMT(CZ) LX22NPO5104
Grant - others:Novo Nordisk Fonden(DK) NNF20SA0066174
Institutional support: RVO:67985823 ; RVO:68378050
Keywords : obesity-induced bone fragility * bone microstructure * bone marrow mesenchymal stem cells * bone marrow adiposity * thiazolidinedione analog MSDC-0602K * pioglitazone
OECD category: Physiology (including cytology)
Impact factor: 8.1, year: 2022
Method of publishing: Open access
https://doi.org/10.1016/j.molmet.2022.101598
Permanent Link: https://hdl.handle.net/11104/0334944